{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:06:34Z","timestamp":1788581194640,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.bcp.2019.04.028","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T18:07:53Z","timestamp":1556302073000},"page":"58-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["New insights of poly(ADP-ribosylation) in neurodegenerative diseases: A focus on protein phase separation and pathologic aggregation"],"prefix":"10.1016","volume":"167","author":[{"given":"Cong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4123-0174","authenticated-orcid":false,"given":"Yanshan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bcp.2019.04.028_b0005","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1007\/s11064-012-0895-x","article-title":"Activation of PARP by oxidative stress induced by \u03b2-amyloid: implications for Alzheimer's disease","volume":"37","author":"Abeti","year":"2012","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.bcp.2019.04.028_b0010","first-page":"247","article-title":"Alpha-synuclein inhibits poly (ADP-ribose) polymerase-1 (PARP-1) activity via NO-dependent pathway","volume":"47","author":"Adamczyk","year":"2009","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.bcp.2019.04.028_b0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nature06420","article-title":"Poly(ADP-ribose)-binding zinc finger motifs in DNA repair\/checkpoint proteins","volume":"451","author":"Ahel","year":"2008","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bcp.2019.04.028_b0020","doi-asserted-by":"crossref","first-page":"8088","DOI":"10.1038\/ncomms9088","article-title":"Liquid demixing of intrinsically disordered proteins is seeded by poly(ADP-ribose)","volume":"19","author":"Altmeyer","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2019.04.028_b0025","doi-asserted-by":"crossref","first-page":"18308","DOI":"10.1073\/pnas.0606526103","article-title":"Poly(ADP-ribose) (PAR) polymer is a death signal","volume":"103","author":"Andrabi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2019.04.028_b0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bcp.2014.06.021","article-title":"Poly(ADP-ribose): a signaling molecule in different paradigms of cell death","volume":"92","author":"Aredia","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2019.04.028_b0035","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.molcel.2015.01.034","article-title":"Biology of poly(ADP-Ribose) polymerases: the factotums of cell maintenance","volume":"58","author":"Bai","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2019.04.028_b0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mito.2015.07.005","article-title":"Poly(ADP-ribosylation) and neurodegenerative disorders","volume":"24","author":"Basello","year":"2015","journal-title":"Mitochondrion"},{"key":"10.1016\/j.bcp.2019.04.028_b0045","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bcp.2019.04.028_b0050","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0197-4580(02)00036-2","article-title":"Alzheimer\u2019s disease and Alzheimer\u2019s dementia: distinct but overlapping entities","volume":"23","author":"Blass","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bcp.2019.04.028_b0055","doi-asserted-by":"crossref","first-page":"15220","DOI":"10.1073\/pnas.1509754112","article-title":"Poly(ADP-ribose) polymerase 1 is a novel target to promote axonal regeneration","volume":"112","author":"Brochier","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2019.04.028_b0060","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3389\/fgene.2018.00712","article-title":"RNA dysregulation in amyotrophic lateral sclerosis","volume":"9","author":"Butti","year":"2019","journal-title":"Front Genet."},{"issue":"6357","key":"10.1016\/j.bcp.2019.04.028_b0065","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.aam9080","article-title":"Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease","volume":"357","author":"Burbulla","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bcp.2019.04.028_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134482","article-title":"PARP-1 inhibition is neuroprotective in the R6\/2 mouse model of Huntington's disease","volume":"10","author":"Cardinale","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2019.04.028_b0075","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0006-8993(96)00918-3","article-title":"Benzamide, an inhibitor of poly(ADP-ribose)polymerase, attenuates methamphetamine-induced dopamine neurotoxicity in the C57B1\/6N mouse","volume":"735","author":"Cosi","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2019.04.028_b0080","article-title":"Poly(ADP-ribosylated) proteins in \u03b2-amyloid peptide-stimulated microglial cells","author":"Correani","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2019.04.028_b0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mcn.2012.06.001","article-title":"Mitochondria and ALS: implications from novel genes and pathways","volume":"55","author":"Cozzolino","year":"2013","journal-title":"Mol. Cell Neurosci."},{"issue":"7533","key":"10.1016\/j.bcp.2019.04.028_b0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature13826","article-title":"Allosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal","volume":"517","author":"DaRosa","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2019.04.028_b0095","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.2174\/092986712802002464","article-title":"Role of PARP inhibitors in cancer biology and therapy","volume":"19","author":"Davar","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2019.04.028_b0100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41422-019-0141-z","article-title":"PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins","volume":"29","author":"Duan","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2019.04.028_b0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.brainres.2011.03.031","article-title":"Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia","volume":"1389","author":"Egi","year":"2011","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.bcp.2019.04.028_b0110","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","article-title":"The amyloid state of proteins in human diseases","volume":"148","author":"Eisenberg","year":"2012","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.bcp.2019.04.028_b0115","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1093\/hmg\/ddx170","article-title":"The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis","volume":"26","author":"Farg","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcp.2019.04.028_b0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"New England J. Med."},{"key":"10.1016\/j.bcp.2019.04.028_b0125","doi-asserted-by":"crossref","first-page":"33926","DOI":"10.1074\/jbc.M109.023879","article-title":"Global analysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells","volume":"284","author":"Frizzell","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2019.04.028_b0130","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6","key":"10.1016\/j.bcp.2019.04.028_b0135","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.molcel.2015.06.001","article-title":"SnapShot: ADP-ribosylation signaling","volume":"58","author":"Hottiger","year":"2015","journal-title":"Mol. Cell."},{"issue":"9996","key":"10.1016\/j.bcp.2019.04.028_b0140","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2019.04.028_b0145","doi-asserted-by":"crossref","first-page":"eaat8407","DOI":"10.1126\/science.aat8407","article-title":"Poly(ADP-ribose) drives pathologic \u03b1-synuclein neurodegeneration in Parkinson\u2019s disease","volume":"362","author":"Kam","year":"2018","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bcp.2019.04.028_b0150","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1212\/01.WNL.0000103291.04985.DC","article-title":"Widespread increased expression of the DNA repair enzyme PARP in brain in ALS","volume":"62","author":"Kim","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.bcp.2019.04.028_b0155","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jnen\/62.1.88","article-title":"PARP expression is increased in astrocytes but decreased in motor neurons in the spinal cord of sporadic ALS patients","volume":"62","author":"Kim","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bcp.2019.04.028_b0160","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.mam.2012.12.005","article-title":"Reprogramming cellular events by poly(ADP-ribose)-binding proteins","volume":"34","author":"Krietsch","year":"2013","journal-title":"Mol. Aspects Med."},{"issue":"12","key":"10.1016\/j.bcp.2019.04.028_b0165","doi-asserted-by":"crossref","first-page":"10690","DOI":"10.1074\/jbc.M110.202507","article-title":"Crystal structures of poly(ADP-ribose) polymerase-1 (PARP-1) zinc fingers bound to DNA: structural and functional insights into DNA-dependent PARP-1 activity","volume":"286","author":"Langelier","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2019.04.028_b0170","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa1105535","article-title":"Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer","volume":"366","author":"Ledermann","year":"2012","journal-title":"New England J. Med."},{"issue":"2","key":"10.1016\/j.bcp.2019.04.028_b0175","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1039\/C6CS00731G","article-title":"Towards an understanding of amyloid-\u03b2 oligomers: characterization, toxicity mechanisms, and inhibitors","volume":"46","author":"Lee","year":"2017","journal-title":"Chem. Soc. Rev."},{"issue":"5","key":"10.1016\/j.bcp.2019.04.028_b0180","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1083\/jcb.201402114","article-title":"Poly(ADP-ribose): an organizer of cellular architecture","volume":"205","author":"Leung","year":"2014","journal-title":"J. Cell Biol."},{"issue":"9","key":"10.1016\/j.bcp.2019.04.028_b0185","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","article-title":"Amyloid fibril structure of \u03b1-synuclein determined by cryo-electron microscopy","volume":"28","author":"Li","year":"2018","journal-title":"Cell Res."},{"issue":"51","key":"10.1016\/j.bcp.2019.04.028_b0190","doi-asserted-by":"crossref","first-page":"20913","DOI":"10.1073\/pnas.1218792109","article-title":"Out-of-register \u03b2-sheets suggest a pathway to toxic amyloid aggregates","volume":"109","author":"Liu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2019.04.028_b0195","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/brain\/122.2.247","article-title":"Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease","volume":"122","author":"Love","year":"1999","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.bcp.2019.04.028_b0200","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41594-018-0050-8","article-title":"Atomic structures of FUS LC domain segments reveal bases for reversible amyloid fibril formation","volume":"25","author":"Luo","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bcp.2019.04.028_b0205","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1073\/pnas.96.10.5774","article-title":"Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism","volume":"96","author":"Mandir","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2019.04.028_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072169","article-title":"PARP-1 modulates amyloid beta peptide-induced neuronal damage","volume":"8","author":"Martire","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2019.04.028_b0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mad.2015.04.001","article-title":"PARP-1 involvement in neurodegeneration: a focus on Alzheimer's and Parkinson's diseases","volume":"146\u2013148","author":"Martire","year":"2015","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bcp.2019.04.028_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2018.07.002","article-title":"Poly(ADP-Ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization","author":"McGurk","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2019.04.028_b0225","doi-asserted-by":"crossref","DOI":"10.1021\/acs.biochem.8b00910","article-title":"Poly(ADP-ribose) engages the TDP-43 nuclear-localization sequence to regulate granulo-filamentous aggregation","author":"McGurk","year":"2018","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.bcp.2019.04.028_b0230","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40478-018-0586-1","article-title":"Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis","volume":"6","author":"McGurk","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"20","key":"10.1016\/j.bcp.2019.04.028_b0235","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1021\/jm8001263","article-title":"4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1","volume":"51","author":"Menear","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2019.04.028_b0240","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/bph.12476","article-title":"Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?","volume":"171","author":"Muyderman","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2019.04.028_b0245","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.semcdb.2016.11.007","article-title":"Poly(ADP-ribose)polymerase-1 hyperactivation in neurodegenerative diseases: the death knell tolls for neurons","volume":"63","author":"Narne","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2019.04.028_b0250","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.tig.2018.03.001","article-title":"ALS Genes in the Genomic Era and their Implications for FTD","volume":"34","author":"Nguyen","year":"2018","journal-title":"Trends Genet."},{"key":"10.1016\/j.bcp.2019.04.028_b0255","doi-asserted-by":"crossref","first-page":"16088","DOI":"10.1074\/jbc.M112.349183","article-title":"ADP-ribosylhydrolase 3 (ARH3), not poly(ADP-ribose) glycohydrolase (PARG) isoforms, is responsible for degradation of mitochondrial matrix-associated poly(ADP-ribose)","volume":"287","author":"Niere","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.bcp.2019.04.028_b0260","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1016\/S0021-9258(19)34205-X","article-title":"Enzymic adenosine diphosphate ribosylation of histone and poly adenosine diphosphate ribose synthesis in rat liver nuclei","volume":"243","author":"Nishizuka","year":"1968","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2019.04.028_b0265","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34334","article-title":"Serine is the major residue for ADP-ribosylation upon DNA damage","volume":"7","author":"Palazzo","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2019.04.028_b0270","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fnana.2017.00061","article-title":"Selective sparing of striatal interneurons after Poly (ADP-Ribose) polymerase 1 inhibition in the R6\/2 mouse model of Huntington's disease","volume":"11","author":"Paldino","year":"2017","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.bcp.2019.04.028_b0275","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fncel.2013.00030","article-title":"Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities","volume":"7","author":"Pirooznia","year":"2013","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.bcp.2019.04.028_b0280","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","article-title":"Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis","volume":"12","author":"Prasad","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bcp.2019.04.028_b0285","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1471-2164-6-139","article-title":"In silico characterization of the family of PARP-like poly(ADP-ribosyl)transferases (pARTs)","volume":"6","author":"Otto","year":"2005","journal-title":"BMC Genomics"},{"issue":"20","key":"10.1016\/j.bcp.2019.04.028_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399403006549","article-title":"Huntington's disease: molecular basis of neurodegeneration","volume":"5","author":"Rubinsztein","year":"2003","journal-title":"Expert Rev. Mol. Med."},{"issue":"46","key":"10.1016\/j.bcp.2019.04.028_b0295","doi-asserted-by":"crossref","first-page":"30069","DOI":"10.1074\/jbc.273.46.30069","article-title":"Poly(ADP-ribose) polymerase null mouse cells synthesize ADP-ribose polymers","volume":"273","author":"Shieh","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"860\u2013871","key":"10.1016\/j.bcp.2019.04.028_b0300","article-title":"A poly-ADP-ribose trigger releases the auto-inhibition of a chromatin remodeling oncogene","volume":"68","author":"Singh","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2019.04.028_b0305","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nature10404","article-title":"The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase","volume":"477","author":"Slade","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2019.04.028_b0310","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12035-012-8258-9","article-title":"Poly(ADP-ribose) polymerase-1 in amyloid beta toxicity and Alzheimer's disease","volume":"46","author":"Strosznajder","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2019.04.028_b0315","doi-asserted-by":"crossref","first-page":"847","DOI":"10.18388\/abp.2000_4003","article-title":"Effect of amyloid beta peptideon poly(ADP-ribose) polymerase activity in adult and aged rat hippocampus","volume":"47","author":"Strosznajder","year":"2000","journal-title":"Acta Biochim. Pol."},{"issue":"10","key":"10.1016\/j.bcp.2019.04.028_b0320","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/s41419-018-1022-y","article-title":"Distinct multilevel misregulations of Parkin and PINK1 revealed in cell and animal models of TDP-43 proteinopathy","volume":"9","author":"Sun","year":"2018","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.bcp.2019.04.028_b0325","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1007\/s11064-016-1864-6","article-title":"Neuroprotective effects of poly(ADP-ribose)polymerase inhibitor olaparib in transient cerebral ischemia","volume":"41","author":"Teng","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bcp.2019.04.028_b0330","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1212\/01.WNL.0000129697.01779.0A","article-title":"The importance of neuritic plaques and tangles to the development and evolution of AD","volume":"62","author":"Tiraboschi","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2019.04.028_b0335","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/10715762.2013.857018","article-title":"Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Abeta(1\u201342)-induced rat model of Alzheimer\u2019s disease","volume":"48","author":"Turunc Bayrakdar","year":"2014","journal-title":"Free Radical Res."},{"issue":"10107","key":"10.1016\/j.bcp.2019.04.028_b0340","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"van Es","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2019.04.028_b0345","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fneur.2018.00173","article-title":"Dysfunction of protein quality control in parkinsonism-dementia complex of Guam","volume":"9","author":"Verheijen","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bcp.2019.04.028_b0350","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00401-004-0957-5","article-title":"Expression pattern of apoptosis-related markers in Huntington's disease","volume":"109","author":"Vis","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bcp.2019.04.028_b0355","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1749-6632.2003.tb07471.x","article-title":"Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson\u2019s disease","volume":"991","author":"Wang","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219301637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219301637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:07:29Z","timestamp":1757768849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219301637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":71,"alternative-id":["S0006295219301637"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.04.028","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New insights of poly(ADP-ribosylation) in neurodegenerative diseases: A focus on protein phase separation and pathologic aggregation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.04.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}